SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$20.67
-1.90% today
Updated 2026-04-29
Market cap
$2.18B
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-7.13
Dividend yield
—
52W range
$10 – $65
Volume
2.9M
Sarepta Therapeutics Inc (SRPT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-32.5%
Last 4 quarters
Revenue YoY growth
-32.7%
Most recent quarter
EPS YoY growth
-288.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-32.5%
2025-11-03
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-3.58 | -241.0% | $16.32 | $16.09 | -1.4% |
| 2025-11-03 | $-0.13 | +81.4% | $24.01 | $16.20 | -32.5% |
| 2025-08-06 | $2.02 | +188.6% | $16.75 | $17.96 | +7.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.05 | $-3.58 | -241.0% | $442.93M | -32.7% |
| 2025-09-30 | $-0.70 | $-0.13 | +81.4% | $399.36M | -14.5% |
| 2025-06-30 | $0.70 | $2.02 | +188.6% | $611.09M | +68.4% |
| 2025-03-31 | $-0.65 | $-3.42 | -426.6% | $744.86M | +80.2% |
| 2024-12-31 | $2.06 | $1.90 | -7.8% | $658.41M | +65.9% |
| 2024-09-30 | $-0.13 | $0.34 | +361.5% | $467.17M | +40.8% |
| 2024-06-30 | $0.01 | $0.07 | +600.0% | $362.93M | +38.9% |
| 2024-03-31 | $-0.07 | $0.37 | +628.6% | $413.46M | +63.1% |
| 2023-12-31 | $0.01 | $0.47 | +4600.0% | $396.78M | — |
| 2023-09-30 | $-1.23 | $-0.46 | +62.6% | $331.82M | — |
| 2023-06-30 | $-1.78 | $-0.27 | +84.8% | $261.24M | — |
| 2023-03-31 | $-1.38 | $-5.86 | -324.6% | $253.50M | — |
Frequently asked questions
Has Sarepta Therapeutics Inc beaten earnings estimates?
Sarepta Therapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -32.5% over the last 4 quarters.
How does SRPT stock react to earnings?
SRPT stock has moved an average of -8.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Sarepta Therapeutics Inc's revenue growth rate?
Sarepta Therapeutics Inc reported year-over-year revenue growth of -32.7% in its most recent quarter, with EPS growing -288.4% year-over-year.